Drugs / CD10367
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03025282 | Nov 2016 → Mar 2017 | psoriasis | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD10367 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03025282 ↗ |